GB892117A - Phenanthridine salts and their preparation - Google Patents

Phenanthridine salts and their preparation

Info

Publication number
GB892117A
GB892117A GB1990058A GB1990058A GB892117A GB 892117 A GB892117 A GB 892117A GB 1990058 A GB1990058 A GB 1990058A GB 1990058 A GB1990058 A GB 1990058A GB 892117 A GB892117 A GB 892117A
Authority
GB
United Kingdom
Prior art keywords
group
general formula
aryl group
prepared
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1990058A
Inventor
Samuel Sidney Berg
William Robert Wragg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
May and Baker Ltd
Original Assignee
May and Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May and Baker Ltd filed Critical May and Baker Ltd
Priority to GB1990058A priority Critical patent/GB892117A/en
Publication of GB892117A publication Critical patent/GB892117A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention comprises: compounds of the general formula <FORM:0892117/IV (b)/1> (where R1 represents a m- or p-guanidinophenyl-diazoamino or a m- or p-guanidinoiminomethyl-phenyldiazoamino group, R2 an aryl group, R3 a C1-6 alkyl group and Y- an anion) and their acid addition salts; the preparation thereof by diazotizing m- or p-aminophenylguanidine or m- or p-aminobenzylidineaminoguanidine and coupling with an equimolecular proportion of a phenanthridinium salt of the general formula <FORM:0892117/IV (b)/2> and pharmaceutical compositions containing the products (see Group VI). The compounds can also be made by diazotizing the 7-amino group of a compound of the second general formula above and coupling with m- or p-aminophenyl-guanidine or m- or p-aminobenzyl?deneamino-guanidine. According to the Provisional Specification, R5 may also represent a substituted aryl group (e.g. p-aminophenyl or p-nitrophenyl). p-Aminobenzylideneaminoguanidine is prepared by acid hydrolysis of the corresponding p-acetamido compound, and is isolated as its bicarbonate. m-Aminobenzylideneaminoguanidine (isolated as its dihydrochloride) is prepared by reduction of the corresponding m-nitro compound, itself prepared from m-nitrobenzaldehyde and aminoguanidine bicarbonate.ALSO:Pharmaceutical compositions, active against blood parasites, comprise, in association with a pharmaceutical carrier, at least one phenanthridinium salt of the general formula <FORM:0892117/VI/1> wherein R1 represents a m- or p-guanidinophenyldiazoamino or a m- or p-guanidinoiminomethylphenyldiazoamino group, R2 an aryl group, R3 a C1-6 alkyl group and Y- an anion (e.g. a chloride, bromide, embonate or suramin ion), or an acid addition salt (e.g. hydrohalide, phosphate, nitrate, sulphate, maleate, fumarate, citrate, tartrate, methanesulphonate or ethanedisulphonate) thereof. They may take the form of solutions, suspensions or emulsions (which may be sterilized and may contain wetting, emulsifying or dispersing agents), tablets, pills, dispersible powders, granules, syrups, elixirs and capsules. According to the Provisional Specification, R2 may also represent a substituted aryl group.
GB1990058A 1958-06-20 1958-06-20 Phenanthridine salts and their preparation Expired GB892117A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1990058A GB892117A (en) 1958-06-20 1958-06-20 Phenanthridine salts and their preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1990058A GB892117A (en) 1958-06-20 1958-06-20 Phenanthridine salts and their preparation

Publications (1)

Publication Number Publication Date
GB892117A true GB892117A (en) 1962-03-21

Family

ID=10137025

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1990058A Expired GB892117A (en) 1958-06-20 1958-06-20 Phenanthridine salts and their preparation

Country Status (1)

Country Link
GB (1) GB892117A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8148429B2 (en) 2000-08-07 2012-04-03 Anamar Ab Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8148429B2 (en) 2000-08-07 2012-04-03 Anamar Ab Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
US8309609B2 (en) 2000-08-07 2012-11-13 Anamar Ab Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
US8410174B2 (en) 2000-08-07 2013-04-02 Anamar Ab Method for treating arthritis
US9227927B2 (en) 2000-08-07 2016-01-05 Anamar Ab Method of treating inflammation

Similar Documents

Publication Publication Date Title
GB1437136A (en) Anti-inflammatory thiazole compounds compositions and methods for using same
US2742393A (en) Derivatives of 2-mercaptopyridine-1-oxide
JPS5692893A (en) Novel cephem compound, its preparation, and preventive and remedy for bacteriosis containing said compound as effective component
GB1399834A (en) Pharmaceutical compositions
GB892117A (en) Phenanthridine salts and their preparation
GB1142066A (en) New diphenyl-ureas and process for preparing them
GB911551A (en) 1-[2-(c alkyl)-4-amino-5-pyrimidylmethyl]-(c alkyl)-pyridinium quaternary salts and compositions containing them
ES8405011A1 (en) Iodopropargyl ammonium salts, process for their preparation and their use as microbicides.
GB1126002A (en) New basic ethers and process for preparing same
ES343003A1 (en) Tetrahydroisoquinoline compounds and preparation thereof
ES8503347A1 (en) Piperidine-3-carboxylic acid derivatives, process for their preparation, and pharmaceutical compositions containing them.
GB1353508A (en) Aminoisoquinolines
US4045483A (en) Amidinoureas and amidinothioureas
GB1296802A (en)
GB842325A (en) Pharmaceutical compositions containing aminoguanidine derivatives
GB1177145A (en) Heterocyclic Allylic Amines
US2794038A (en) Halogenated mercurisulfonates
GB1021522A (en) 2-quinolone derivatives
US2578536A (en) Emetine penicillin
GB865973A (en) Manufacture of phenyl-quinuclidines
GB880934A (en) Improvements in or relating to phenthiazine derivatives
US3619167A (en) Herbicidal compositions containing bipyridylium salts with reduced corrosiveness toward metals
GB1017450A (en) 2-amino-4-alkoxy-úË-triazines
GB901643A (en) Phenanthridinium salts and their preparation
GB872202A (en) New phenthiazine derivatives